Читать книгу Microbial Interactions at Nanobiotechnology Interfaces - Группа авторов - Страница 36

Every year millions of people suffer from severe illness due to antibacterial resistance and the mortality rate is expected to reach 10 million by 2050 (Gupta et al., 2019). For patients having such infections, antibiotic therapy is the most common treatment used with removal of infected tissue in few cases. There are many disadvantages to such treatments. Along with the high cost, these treatments make the condition worse by increasing antibiotic tolerance of the surviving bacteria. Therefore, it becomes important to find new ways to tackle such problem. Recent advancement in the field of nanotechnology provides new prospects to develop novel NMs with antimicrobial properties. Various NMs have been synthesized to defend against multidrug resistance (MDR) and microbial resistance. NMs have the ability to act not only against bacteria but also as carrier for synthetic and natural antimicrobial compounds. Different NMs have different mechanisms to combat bacteria.